Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy - PubMed (original) (raw)
Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy
S J Szilvassy et al. Proc Natl Acad Sci U S A. 1990 Nov.
Abstract
Although hematopoiesis is known to originate in a population of very primitive cells with both lymphopoietic and myelopoietic potential, a procedure for enumerating such cells has to date not been available. We now describe a quantitative assay for long-term repopulating stem cells with the potential for reconstituting all hematopoietic lineages. This assay has two key features. The first is the use of competitive repopulation conditions that ensure not only the detection of a very primitive class of hematopoietic stem cells but also the survival of lethally irradiated mice transplanted with very low numbers of such cells. The second is the use of a limiting-dilution experimental design to allow stem cell quantitation. The assay involves transplanting limiting numbers of male "test" cells into lethally irradiated syngeneic female recipients together with 1-2 x 10(5) syngeneic female marrow cells whose long-term repopulating ability has been compromised by two previous cycles of marrow transplantation. The proportion of assay recipients whose regenerated hematopoietic tissues are determined to contain greater than or equal to 5% cells of test cell origin (male) greater than or equal to 5 weeks later is then used to calculate the frequency of competitive repopulating units (CRU) in the original male test cell suspension (based on Poisson statistics). Investigation of this assay system has shown that all three potential sources of stem cells (test cells, compromised cells, and the host) can under appropriate circumstances contribute to long-term hematopoietic regeneration, thus establishing both the competitive pressure of hematopoietic stem cells in the cotransplanted compromised population and in the host, and the need to use genetic markers to track the specific contribution of the injected test cells. Analysis of the frequency of CRU in test marrow suspensions that varied widely in their CRU content gave similar values when endpoints of either 5 or 10 weeks posttransplantation were used and when either recipient marrow or thymus was used to identify progeny populations. In addition, repopulation of marrow and thymus was found to be associated in most mice injected with limiting numbers of test cells. These findings are consistent with the conclusion that the assay is highly selective for a very primitive, totipotent, reconstituting hematopoietic stem cell and should therefore be particularly useful in future gene therapy-oriented research as well as for more basic studies of hematopoietic stem cell regulation and differentiation.
Similar articles
- Proliferation of totipotent hematopoietic stem cells in vitro with retention of long-term competitive in vivo reconstituting ability.
Fraser CC, Szilvassy SJ, Eaves CJ, Humphries RK. Fraser CC, et al. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1968-72. doi: 10.1073/pnas.89.5.1968. Proc Natl Acad Sci U S A. 1992. PMID: 1311857 Free PMC article. - Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells.
Szilvassy SJ, Weller KP, Lin W, Sharma AK, Ho AS, Tsukamoto A, Hoffman R, Leiby KR, Gearing DP. Szilvassy SJ, et al. Blood. 1996 Jun 1;87(11):4618-28. Blood. 1996. PMID: 8639830 - Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow.
Holyoake TL, Nicolini FE, Eaves CJ. Holyoake TL, et al. Exp Hematol. 1999 Sep;27(9):1418-27. doi: 10.1016/s0301-472x(99)00078-8. Exp Hematol. 1999. PMID: 10480433 - Hematopoietic stem cells: inferences from in vivo assays.
Eaves C, Miller C, Cashman J, Conneally E, Petzer A, Zandstra P, Eaves A. Eaves C, et al. Stem Cells. 1997;15 Suppl 1:1-5. doi: 10.1002/stem.5530150802. Stem Cells. 1997. PMID: 9368318 Review. - Stem cell plasticity in muscle and bone marrow.
Goodell MA, Jackson KA, Majka SM, Mi T, Wang H, Pocius J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hirschi KK. Goodell MA, et al. Ann N Y Acad Sci. 2001 Jun;938:208-18; discussion 218-20. doi: 10.1111/j.1749-6632.2001.tb03591.x. Ann N Y Acad Sci. 2001. PMID: 11458510 Review.
Cited by
- Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.
Kamio T, Gu BW, Olson TS, Zhang Y, Mason PJ, Bessler M. Kamio T, et al. PLoS One. 2016 Apr 4;11(4):e0152263. doi: 10.1371/journal.pone.0152263. eCollection 2016. PLoS One. 2016. PMID: 27042854 Free PMC article. - Mobilization of hematopoietic stem/progenitor cells: general principles and molecular mechanisms.
Bonig H, Papayannopoulou T. Bonig H, et al. Methods Mol Biol. 2012;904:1-14. doi: 10.1007/978-1-61779-943-3_1. Methods Mol Biol. 2012. PMID: 22890918 Free PMC article. Review. - Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function.
Garaycoechea JI, Crossan GP, Langevin F, Daly M, Arends MJ, Patel KJ. Garaycoechea JI, et al. Nature. 2012 Sep 27;489(7417):571-5. doi: 10.1038/nature11368. Epub 2012 Aug 26. Nature. 2012. PMID: 22922648 - Defects in hemopoietic stem cell activity in Ikaros mutant mice.
Nichogiannopoulou A, Trevisan M, Neben S, Friedrich C, Georgopoulos K. Nichogiannopoulou A, et al. J Exp Med. 1999 Nov 1;190(9):1201-14. doi: 10.1084/jem.190.9.1201. J Exp Med. 1999. PMID: 10544193 Free PMC article.
References
- Science. 1988 Jul 1;241(4861):58-62 - PubMed
- Blood. 1989 Aug 15;74(3):930-9 - PubMed
- Cell. 1985 Aug;42(1):71-9 - PubMed
- Radiat Res. 1961 Feb;14:213-22 - PubMed
- Proc Natl Acad Sci U S A. 1989 Nov;86(22):8798-802 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical